This inventor holds 1 USPTO granted patent. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Yusuke Kawabe: Innovator in Pharmaceutical Compounds
Introduction
Yusuke Kawabe is a notable inventor based in Azumino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Kawabe holds a patent for hypoxanthine compounds. This invention relates to hypoxanthine compounds or pharmaceutically acceptable salts thereof. The compounds exhibit a prolyl hydroxylase inhibitory effect and are useful as agents for treating inflammatory bowel diseases, such as ulcerative colitis. The patent outlines a method for treating these conditions by administering a pharmaceutical composition containing the hypoxanthine compound or its salts.
Career Highlights
Yusuke Kawabe is associated with Kissei Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical innovations. His work focuses on creating effective treatments for various medical conditions.
Collaborations
Kawabe collaborates with talented colleagues, including Haruka Ohtsuki and Kyosuke Nakamura. Their combined expertise contributes to the innovative environment at Kissei Pharmaceutical.
Conclusion
Yusuke Kawabe's contributions to pharmaceutical science, particularly through his patent on hypoxanthine compounds, highlight his role as an innovator in the field. His work continues to pave the way for advancements in treatments for inflammatory bowel diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile